NIASTASE RT
NIASTASE RT
Approved
DIN Number
02417111
Drug Class
Human
Market Date
May 5, 2015
Company
HC
Novo Nordisk Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02417111
AIG Number0136061005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
B02BD08 COAGULATION FACTOR VIIa
Product Specifications
Dosage FormKit
,
Powder For Solution
Route of AdministrationIntravenous
AHFS Classification20:28.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
EPTACOG ALFA (ACTIVATED)Active
Strength: 2 MG / VIAL
Monograph: EPTACOG ALFA (ACTIVATED)